文献速递胃肠外科围术期管理与 ERAS

直肠癌手术围术期微生物组变化:NIHR IntAct 试验探索性分析

Perioperative changes in the microbiome during rectal cancer surgery: exploratory analysis of the National Institute for Health and Care Research (NIHR) IntAct trial.
PubMed 文献 · Br J Surg · 2025-01-01

该研究基于 NIHR IntAct 试验,对 202 例直肠癌手术患者采集基线、手术当日及术后第 3-5 天直肠拭子,行 16S rRNA 测序及产胶原酶菌培养。结果显示,beta 多样性受医院站点、机械性肠道准备、口服抗生素、造口等因素影响,alpha 多样性随时间下降;吻合口漏患者与无漏者在 alpha 或 beta 多样性上无显著差异。

要点

  • 直肠癌围术期微生物组发生可测量变化,alpha 多样性随时间下降,肠球菌和普雷沃菌术后增多。
  • beta 多样性与医院站点、机械性肠道准备、术前口服抗生素及造口相关。
  • 吻合口漏与无漏患者在 alpha 或 beta 多样性上未见显著差异。

核心结论

  • 直肠癌手术围术期微生物组发生可测量变化,但吻合口漏与无漏者间 alpha 或 beta 多样性无显著差异。

研究设计与样本

  • 基于 NIHR IntAct 试验的探索性分析,共纳入 202 例直肠癌手术患者(平均年龄 65 岁,69.8% 男性)。
  • 在基线、手术当日及术后第 3-5 天采集直肠拭子,行 16S rRNA 测序及产胶原酶菌培养。

主要发现

  • 基线时吸烟状态解释 beta 多样性变异的 3.2%(P = 0.046)。
  • 手术当日 beta 多样性与医院站点(11.1%;P = 0.033)、机械性肠道准备(2.6%;P = 0.024)及术前口服抗生素(1.0%;P = 0.020)相关。
  • 术后 beta 多样性受医院站点(16.3%;P < 0.001)、造口(2.9%;P = 0.003)及术前口服抗生素(1.6%;P = 0.006)影响。
  • alpha 多样性随时间下降,术后肠球菌和普雷沃菌增加;造口与较低 alpha 多样性及假单胞菌、链球菌增加相关。
  • 吻合口漏与无漏者间 alpha 或 beta 多样性无显著差异,但检出低丰度分类群细微差异,且 43.6% 术后样本显示胶原酶活性。

临床怎么用

  • 围术期微生物组受医院站点、肠道准备、口服抗生素及造口等因素影响,临床解读微生物数据时需考虑这些变量。

局限性

  • 本研究为探索性分析,微生物组变化与吻合口漏的临床意义尚不明确,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The gut microbiome may influence postoperative outcomes after rectal cancer surgery, including anastomotic leak. However, perioperative microbiome dynamics and their association with outcomes remain poorly understood. The aim of this study was to characterize changes in the rectal microbiome in patients undergoing rectal cancer surgery within the National Institute for Health and Care Research (NIHR) IntAct trial. METHODS: Rectal swabs were collected at baseline, day of surgery, and postoperative day 3-5. DNA was extracted for 16S ribosomal RNA (rRNA) sequencing and collagenase-producing organisms were identified by culture. Associations between microbiome composition and clinical variables were analysed. RESULTS: A total of 202 patients were included (mean age 65 years; 69.8% male). At baseline, smoking status explained 3.2% of variation in beta-diversity (P = 0.046). On the day of surgery, beta-diversity was associated with hospital site (11.1%; P = 0.033), mechanical bowel preparation (2.6%; P = 0.024), and preoperative oral antibiotics (1.0%; P = 0.020). After surgery, hospital site (16.3%; P < 0.001), a defunctioning stoma (2.9%; P = 0.003), and preoperative oral antibiotics (1.6%; P = 0.006) influenced beta-diversity. Alpha-diversity decreased over time, with postoperative increases in Enterococcus and Prevotella. A defunctioning stoma was associated with lower alpha-diversity and increased Pseudomonas and Streptococcus. No significant difference in alpha- or beta-diversity was observed between patients with and without anastomotic leak, although subtle differences in taxa of low abundance were detected and 43.6% of postoperative samples demonstrated collagenase activity. CONCLUSION: This is the largest study to date describing perioperative microbiome changes in patients undergoing rectal cancer surgery. Measurable shifts in the microbiome were observed, with small differences between patients with and without anastomotic leak. Further research is needed to explore the clinical significance of these microbiome changes. The gut microbiome is the community of bacteria living in human intestines. These bacteria usually help keep humans healthy, but sometimes they cause illness. For people having surgery to remove rectal cancer, a serious complication is when the join between two parts of the bowel does not heal properly, known as anastomotic leak. Changes in the gut microbiome may contribute to this life-threatening problem. The aim of this study was to understand how the gut microbiome changes before, during, and after rectal cancer surgery, and whether these changes are related to postoperative outcomes, including anastomotic leak. A total of 202 patients having rectal cancer surgery at several NHS hospitals were studied. Samples from the rectum were collected before surgery, during surgery, and a few days after, and analysed to identify the types of bacteria present and their potential effects. The authors found that the mix of bacteria changed during treatment. Factors such as smoking, hospital location, bowel cleaning medication, and the use of a defunctioning stoma (a small opening to divert stool) affected the bacterial community. Many patients had bacteria that produce enzymes that may damage tissue. Although there were small differences in the microbiome between patients with and without leaks, no clear link was found. The study shows that the gut microbiome changes during rectal cancer surgery and is influenced by treatment choices. While small differences in those with leaks were found, more research is needed. Understanding these changes in bacteria could help to prevent complications after surgery.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Helliwell JA, Chilton CH, Young C, et al. Perioperative changes in the microbiome during rectal cancer surgery: exploratory analysis of the National Institute for Health and Care Research (NIHR) IntAct trial. Br J Surg. 2025. PMID: 41025606. doi:10.1093/bjs/znaf199

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。